Vita Life Sciences Limited announced consolidated earnings results for the half year ended June 30, 2016. For the half year, the company reported revenue was AUD 18.1 million against AUD 18.2 million a year ago. EBITDA was AUD 3.1 million against AUD 2.4 million a year ago. EBIT was AUD 3.0 million against AUD 2.4 million a year ago. Profit before tax was AUD 2.9 million against AUD 2.3 million a year ago. Profit after tax was AUD 1.8 million against AUD 1.6 million a year ago. Diluted EPS was 3.3 cents against 2.8 cents a year ago. Gross operating cash flow was AUD 1.0 million against AUD 3.4 million a year ago. Operating cash flows was AUD 0.9 million against AUD 3.0 million a year ago

Based on trading to June 2016 and no material changes within the company's regions of operation directors provide the following guidance for the 2016 full year. The full year revenue is expected to be AUD 39 million and full year EBIT is expected of AUD 6.00 million to AUD 6.75 million.